top of page

 
業績｜論文・出版物｜目次｜
 

2022

Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatment.

Tazawa H., Shigeyasu K., Noma K., Kagawa S., Sakurai F., Mizuguchi H., Kobayashi H., Imamura T., Fujiwara T.

Cancer Sci., 113, 1919-1929 (2022)

PubMed

Adenovirus vector-based vaccine for infectious diseases.

Sakurai F., Tachibana M., Mizuguchi H.

Drug Metab. Pharmacokinet., 42, 100432 (2022)

PubMed

ZFAND3 Overexpression in the Mouse Liver Improves Glucose Tolerance and Hepatic Insulin Resistance.

Shimizu K., Ogiya Y., Yoshinaga K., Kimura H., Michinaga .S, Ono M., Taketomi A., Terada T., Sakurai F., Mizuguchi H., Tomita K., Nishinaka T.

Exp. Clin. Endocrinol. Diabetes, 130, 254-261 (2022)

PubMed

A dopamine antagonist, domperidone, enhances the replication of an oncolytic adenovirus in human tumor cells.

Nishimae F., Sakurai F., Ono R., Onishi R., Takayama K., Mizuguchi H.

J. Gen. Virol, 103, 1752 (2022)

PubMed

Adenovirus vector with ADP gene induces cytopathic effects in HEK293 cells without significant elevation of virus titers.

Shiota A., Nishimae F., Sakurai F., Mizuguchi H.

Anticancer Res., 42, 1719-1727 (2022)

PubMed

Decellularized Organ-Derived Scaffold Is a Promising Carrier for Human Induced Pluripotent Stem Cells-Derived Hepatocytes.

Kojima H., Yagi H., Kushige H., Toda Y., Takayama K., Masuda S., Morisaku T., Tsuchida T., Kuroda K., Hirukawa K., Inui J., Nishi K., Nakano Y., Tanaka M., Hori S., Hasegawa Y., Abe Y., Kitago M., Adachi S., Tomi M., Matsuura K., Mizuguchi H., Kitagawa Y.

Cells, 11, 1258 (2022)

PubMed

A doxycycline-inducible CYP3A4-Caco-2 cell line as a model for evaluating safety of aflatoxin B1 in the human intestine.

Bai, L., Tachibana, K., Murata, M., Inoue, T., Mizuguchi, H., Maeda, S., Ikemura, K., Okuda, M., Kusakabe, T., Kondoh, M.

Toxicol Lett., 370, 1-6 (2022)

PubMed

Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus.

Ono R., Nishimae F., Wakida T., Sakurai F., Mizuguchi H.

Sci. Rep., 12, 21560 (2022)

PubMed

Modified method for differentiation of myeloid-derived suppressor cells in vitro enhances immunosuppressive ability via glutathione metabolism.

Zhou H., Zhiqi X., Morikawa N., Sakurai F., Mizuguchi H., Okuzaki D., Okada N.. Tachibana M.

Biochem. Biophys. Rep., 33, 101416 (2022)

PubMed

Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation and tumor infiltration of natural killer cells

Ono R., Sakurai F., Tokuoka S., Ishii K., Mizuguchi H

BioRxiv (2022)

WebSite

アデノウイルスベクターワクチンの現状と展望

水口裕之、立花雅史、櫻井文教

ドラッグデリバリーシステム, 37, 421-428 (2022)

WebSite

ヒト35型アデノウイルスを基本骨格とした腫瘍溶解性アデノウイルスの開発

櫻井文教、小野良輔、水口裕之

BIO Clinica, 37, 520-524 (2022)

WebSite

アデノウイルスベクターワクチン設計のサイエンス　～COVID-19に対するワクチン開発を中心に～

水口裕之

別冊・医学のあゆみ, 83-88 (2022)

WebSite
bottom of page